Home › Huntington's Disease › District of Columbia
Huntington's Disease clinical trials in District of Columbia
4 studies for Huntington's Disease are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Pridopidine Phase 3 Study in Huntington's Disease
- Georgetown University, Washington D.C.
RecruitingPhase 3
Ages 23 to 65 · All sexes · Updated Sep 30, 2026 · NCT07609108A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
- Georgetown University, Washington D.C.
RecruitingPhase 3
Ages 21 to 70 · All sexes · Updated Sep 22, 2026 · NCT07326709HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
- Georgetown University, Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
Ages 11 to 75 · All sexes · Updated Apr 27, 2026 · NCT02855476Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
- Georgetown University, Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 28, 2024 · NCT01574053From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.